Forecast: Diabetes Medicine Sales in Chile

Diabetes medicine sales in Chile have demonstrated notable growth from 2013 to 2023, experiencing several fluctuations in the year-on-year percentage. The value stood at $317.1 million USD in 2023. From 2022 to 2023, the year-on-year increase was 10.91%, while the average annual variation (CAGR) over the last five years reached 14.01%. The CAGR from 2014 to 2019 fell to around 11.21%, with a slight decrease in 2022.

Looking forward, the forecasted data from 2024 to 2028 suggests a more moderate growth rate with a five-year CAGR of 5.27%, translating to an overall growth of 29.26% over these years. Future trends to watch include technological advancements in diabetes treatment, government healthcare policies, market competition, and potential new entrants affecting pricing and accessibility. Monitoring the impacts of these factors on market demand will be crucial for strategic planning.